These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3720792)

  • 1. Single and multiple dose pharmacokinetics of sultosilic acid in humans.
    Roser R; Martinez L; Pares S; Sagarra R; Esteve J
    Eur J Drug Metab Pharmacokinet; 1986; 11(1):1-7. PubMed ID: 3720792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolism of the hypolipidaemic drug sultosilic acid in rat, dog and man.
    Wood SG; Kirkpatrick D; Jackson AJ; Hawkins DR; Down WH; Chasseaud LF; Biggs SR; Darragh A
    Xenobiotica; 1982 Mar; 12(3):165-76. PubMed ID: 7113253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ebrotidine in healthy volunteers. A summary.
    Albet C; Pérez JA; Rozman E; Márquez M; Herrero E; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):535-9. PubMed ID: 9205760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic study of ebrotidine administered in multiple doses to healthy volunteers for 4 days.
    Frías J; Esteban C; Carcas AJ; Sánchez-García P; Albet C; Torres J; Márquez M; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):531-4. PubMed ID: 9205759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses.
    Mattina R; Bonfiglio G; Cocuzza CE; Gulisano G; Cesana M; Imbimbo BP
    Chemotherapy; 1991; 37(6):389-97. PubMed ID: 1662127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease.
    Bramer SL; Forbes WP; Mallikaarjun S
    Clin Pharmacokinet; 1999; 37 Suppl 2():1-11. PubMed ID: 10702882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of mecillinam in health subjects.
    Gambertoglio JG; Barriere SL; Lin ET; Conte JE
    Antimicrob Agents Chemother; 1980 Dec; 18(6):952-6. PubMed ID: 6263180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and pharmacokinetics of ebrotidine in healthy subjects given single and repeated oral doses.
    Farré M; Roset PN; Badenas JM; Ugena B; Márquez M; Albet C; Herrero E; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):528-30. PubMed ID: 9205758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of brodimoprim.
    Weidekamm E
    J Chemother; 1993 Dec; 5(6):475-9. PubMed ID: 8195840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers.
    Strolin Benedetti M; Whomsley R; Nicolas JM; Young C; Baltes E
    Eur J Clin Pharmacol; 2003 Nov; 59(8-9):621-30. PubMed ID: 14530892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The concentration-dependent disposition of intravenous p-aminohippurate in subjects with normal and impaired renal function.
    Prescott LF; Freestone S; McAuslane JA
    Br J Clin Pharmacol; 1993 Jan; 35(1):20-9. PubMed ID: 8448064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-dose pharmacokinetics and tolerability of gemifloxacin administered orally to healthy volunteers.
    Allen A; Bygate E; Vousden M; Oliver S; Johnson M; Ward C; Cheon A; Choo YS; Kim I
    Antimicrob Agents Chemother; 2001 Feb; 45(2):540-5. PubMed ID: 11158752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of prazosin.
    Jaillon P
    Clin Pharmacokinet; 1980; 5(4):365-76. PubMed ID: 6994981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
    Degen PH; Dieterle W; Schneider W; Theobald W; Sinterhauf U
    Xenobiotica; 1988 Dec; 18(12):1449-55. PubMed ID: 3245235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of etofylline after intravenous and oral administration to humans.
    Zuidema J; Verhoeven J; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.